The global intracranial pressure monitoring devices market size was estimated to be US$ 1.65 billion in 2021 and is expected grow at a CAGR of 7% between 2023 to 2032.
Intracranial pressure monitoring devices are diagnostic devices that measure the intracranial pressure in the skull as a result of accident or injuries. Intra cranial pressure (ICP) monitoring devices use a small pressure-sensitive probe placed into the skull to help doctors assess the pressure of cerebrospinal fluid and whether it is high or low.
This device is useful for diagnosing and treating several neurological conditions such as:
- Traumatic brain injury (TBI)
- Intracerebral hemorrhage
- Subarachnoid hemorrhage
- Hydrocephalus
- Ischemic stroke
- Encephalitis
- Meningitis
- Arteriovenous malformations (AVMs)
- Brain aneurysms
Intracranial pressure monitoring has progressed from an intrusive technique to a non-invasive technology over past decades. The growing incidences of neurovascular disorders and rising cases of trauma and brain injuries have increased the demand for minimally invasive treatments and also increased government initiatives to improve healthcare infrastructure. Such initiatives have accelerated market growth.
Intracranial Pressure (ICP) monitoring devices market dynamics
♦ Increasing cases of coronavirus disease (COVID-19)
Owing to the global pandemic of COVID-19, there has been a considerable increase of cases of patients in life-threatening situations all over the world. As the number of cases increases the demand also increases for high-quality care for patients. Intracranial pressure (ICP) devices are needed to monitor patients in intensive care units in hospitals. Moreover, the rising cases of autoimmune, cardiovascular and sleep diseases has also increased the demand for ICP devices to deliver effective and timely monitoring.
♦ Greater need for innovative intracranial pressure (ICP) devices
National and regional level governments all over the world are investing in enhancing healthcare infrastructure and critical care needs for patients. Private players are investing in new technologies to develop intra cranial pressure monitoring devices for home use. The integration of technologies such as artificial intelligence and cloud computing in ICP monitoring devices will positively impact market growth in the coming years.
♦ High incidence of Traumatic Brain Injury (TBI)
Due to the high number of patients suffering traumatic brain injuries as a result of car accidents, this has led to a huge demand for intracranial pressure monitoring devices globally.
♦ Rising incidence of neurological conditions
Manufacturers of intracranial pressure (ICP) monitoring devices in countries like China, Japan and India have a great opportunity to grow their businesses due to the vast number of elderly patients who are at maximum risk of neurological problems.
Challenges in the ICP monitoring device market
- High Intracranial pressure (ICP) monitoring product cost
Due to the high costs of ICP monitoring devices, the accessibility to patients in developing countries is greatly reduced. These devices are currently out of reach for patients from lower socio-economic backgrounds. Furthermore, intracranial pressure (ICP) monitoring is a complicated operation that requires very qualified and skilled medical professionals since it is an intrusive procedure that necessitates surgery. Any minor errors while placing the probe in the brain can easily lead to patient death. Therefore, the lack of trained medical professionals restrains market growth in this market.
The major players operating in the intra cranial pressure (ICP) monitoring devices market are:
Medtronic, Johnson & Johnson Private Limited, RAUMEDIC AG, Integra LifeSciences, Natus Medical Incorporated, Terumo Corporation, Sophysa, Spiegelberg GmbH & Co. KG, Compumedics Limited, Shurtleff, Inc., HeadSense Medical, NeuroDx Development, Third Eye Diagnostics, Vivonics Inc., Covidien plc, Linet
Market Segmentations:
By Product:
- Intraventricular Catheters
- Subdural Catheters
- Parenchymal Catheters
- Epidural Sensors
- Sub Arachnoid Screws
By Route of Intervention:
- Intraventricular ICP Monitoring
- Subdural ICP Monitoring
- Epidural ICP Monitoring
- Parenchymal ICP Monitoring
- Subarachnoid ICP Monitoring
By Indication
- Traumatic Brain Injury
- Intracerebral Haemorrhage
- Subarachnoid haemorrhage
- Hydrocephalus
- Malignant Cerebral Infarction (MCI)
- Cerebral Edema
- CNS infections
- Others
By End-Use
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
